MP
CCXI

Mangrove Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Mangrove Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-39,774
Closed -$1.45M – 659
2021
Q4 		$1.45M Buy
+39,774
New +$1.4M 0.09% 396
2020
Q4 		– Sell
-353,219
Closed -$19.4M – 128
2020
Q3 		$19.4M Buy
353,219
+209,104
+145% +$11.3M 2.45% 11
2020
Q2 		$8.29M Sell
144,115
-442,408
-75% -$24.1M 2.02% 18
2020
Q1 		$23.6M Buy
+586,523
New +$24.9M 3.25% 7

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Mangrove Partners's CCXI Position: Q1 2022 in Review

Mangrove Partners sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 39,774 shares — an estimated $1.45M sold.

Mangrove Partners first reported a position in CCXI in Q1 2020 and held it in 4 quarters. The position peaked at $23.6M in Q1 2020. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Mangrove Partners reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 39,774 ChemoCentryx, Inc. shares in Q1 2022, an estimated $1.45M.
  • Mangrove Partners first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 4 quarters.
  • Mangrove Partners's ChemoCentryx, Inc. position peaked at $23.6M in Q1 2020.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.